Rhabdomyosarcoma of the head and neck: A clinicopathological and immunohistochemical analysis of 29 cases

Brazilian Dental Journal

Volumn 21, Issue 1, 2010, Pages 68-73

  de Andrade, Cléverton Roberto ^a   Takahama Junior, Ademar ^a   Nishimoto, Inês Nobuko ^b   Kowalski, Luiz Paulo ^b   Lopes, Márcio Ajudarte ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Head neck; Immunohistochemistry; Oral; Prognostic factors; Rhabdomyosarcoma

Indexed keywords

EID: 77955592758     PISSN: 01036440     EISSN: 18064760     Source Type: Journal    
DOI: 10.1590/s0103-64402010000100011     Document Type: Review

References (20)

1. Pappo AS. Rhabdomyosarcoma and other soft tissue sacomas in children. Curr Opin Oncol 1996;8:311-316.
2. Arndt CA, Crist WM. Common musculeskaletal tumors of childhood and adolescence. N Engl J Med 1999;341:342-352.
3. Newton WA Jr, Gehan EA, Webber BL, Marsden HB, van Unnik AJ, Hamoudi AB. Classification of Rhabdomyosarcomas and related sarcomas. Cancer 1995;76:1073-1085.
4. Parham DM, Webber B, Holt H, Williams WK, Maurer H. Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms: results of an intergroup Rhabdomyosarcoma study project. Cancer 1991;67:3072-3080.
5. Lawrence W Jr, Anderson JR, Gehan EA, Maurer H. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the intergroup Rhabdomyosarcoma study group. Children's cancer study group. Pediatric Oncology Group. Cancer 1997;80:1165-1170.
6. Maurer HM, Beltangady M, Gehan EA, Crist W, Hammond D, Hays DM, et al. The intergroup Rhabdomyosarcoma study-I. A final report. Cancer 1988;61:209-220.
7. Schouwenburg PF, Kupperman D, Bakker FP, Blank LECM, de Boer HB, Voute TA. New combined treatment of surgery, radiotherapy, and reconstruction in head and neck rhabdomyosarcoma in children: the AMORE protocol. Head Neck 1998;20:283-292.
8. Ragazzini P, Gamberi G, Pazzaglia L, Serra M, Magagnoli G, Ponticelli F, et al. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Histol Histopathol 2004;19:401-411.
9. Ricci C, Landuzzi L, Rossi I, De Giovanni C, Nicoletti G, Astolfi A, et al. Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells. Int J Cancer 2000;87:29-36.
10. Takahiro T, Shinichi K, Toshimitsu S. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas. Clin Cancer Res 2003;9:2204-2212.
11. Maurer HM, Gehan EA, Beltangady M, Crist W, Dickman PS, Donaldson SS. et al. The intergroup Rhabdomyosarcoma study - II. Cancer 1993;71:1904-1922.
12. Simon JH, Paulino AC, Smith RB, Buatti JM. Prognostic factors in head and neck rhabdomyosarcoma. Head Neck 2002;24:468-473.
13. Cavazzana AO, Schmidt D, Ninfo V, Harms D, Tollot M, Carli M, et al. Spindle cell Rhabdomyosarcoma. Am J Surg Pathol 1992;16:229-235.
14. Al-Khateeb T, Bataineh AB. Rhabdomyosarcoma of the oral and maxillofacial region in Jordanians: a retrospective analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:580-585.
15. Cui S, Hano H, Harada T, Takai S, Masui F, Ushigome S. Evaluation of new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcomas. Pathol Int 1999;49:62-68.
16. Ayan I, Dogan O, Kebudi R, Bavbek B, Alatli C, Dervişoǧlu S, et al. Immunohistochemical detection of p53 protein in rhabdomyosarcoma: association with clinicopathological features and outcome. J Pediatr Hematol Oncol 1997;19:48-53.
17. Barboza CAG, Pinto LP, Freitas RA, Costa ALL, Souza LB. Proliferating cell nuclear antigen (PCNA) and p53 protein expression in ameloblastoma and adenomatoid adontogenic tumor. Braz Dent J 2005;16:56-61.
18. Takahama A. Jr, Alves FA, Pinto CAL, Carvalho AL, Kowalski LP, Lopes MA. Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas. Oral Oncol 2003;39:521-530.
19. Blank LE, Koedooder K, Pieters BR, van der Grient HN, van de Kar M, Buwalda J, et al. The AMORE protocol for advancedstage and recurrent nonorbital rhabdomyosarcoma in the headand- neck region of children: a radiation oncology view. Int J Radiat Oncol Biol Phys 2009;74:1555-1562.
20. Leuschner I, Langhans I, Schmitz R, Harms D, Mattke A, Treuner J. p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study. Pediatr Dev Pathol 2003;6:128-136.